acetylcysteine has been researched along with pramipexole in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Imamura, K; Ito, S; Nakashima, K; Nakaso, K; Takeshima, T | 1 |
Guo, Y; Janokovic, J; Le, W; Li, C; Li, X; Xie, W | 1 |
1 review(s) available for acetylcysteine and pramipexole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for acetylcysteine and pramipexole
Article | Year |
---|---|
Pramipexole has astrocyte-mediated neuroprotective effects against lactacystin toxicity.
Topics: Acetylcysteine; Animals; Astrocytes; Benzothiazoles; Brain-Derived Neurotrophic Factor; Cell Death; Cell Line, Tumor; Cells, Cultured; Cysteine Proteinase Inhibitors; Dopamine Agonists; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Microtubule-Associated Proteins; Neurons; Pramipexole; Pregnancy; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tyrosine 3-Monooxygenase | 2008 |
Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease.
Topics: Acetylcysteine; Animals; Autophagy; Benzothiazoles; Brain-Derived Neurotrophic Factor; Corpus Striatum; Dopamine; Dopamine Agonists; Glial Cell Line-Derived Neurotrophic Factor; Male; Mice; Mice, Inbred C57BL; Microglia; Motor Activity; Neurons; Neuroprotective Agents; Parkinson Disease; Pramipexole; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Receptors, Dopamine D3; Substantia Nigra; Ubiquitin | 2010 |